| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.093 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.095 | 0.03 |